Related Experiment Video
Updated: May 11, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort
Marco R Di Tullio1, Zhezhen Jin, Cesare Russo
1Department of Medicine, Columbia University, New York, NY, USA. md42@columbia.edu
Insights
Patent foramen ovale (PFO) did not increase stroke risk in the general population. This study found no link between PFO and silent brain infarcts, suggesting PFO is not a significant risk factor for cerebrovascular disease.
Area of Science:
- Cardiovascular Research
- Neurology
- Epidemiology
Background:
- Patent foramen ovale (PFO) is more prevalent in stroke patients than in controls.
- The stroke risk associated with PFO in the general population remains unclear.
- The relationship between PFO and silent brain infarcts (SBI) is not established.
Purpose of the Study:
- To investigate the association between PFO and ischemic stroke risk in a general population.
- To determine if PFO is linked to subclinical cerebrovascular disease, specifically SBI.
Main Methods:
- A community-based sample of 1,100 individuals over 39 were followed for 11 years.
- PFO presence was identified using transthoracic echocardiography with saline contrast.
- Brain MRI was used to detect SBI in 360 participants; stroke risk and SBI odds were analyzed adjusting for risk factors.
Main Results:
- PFO was present in 14.9% of participants.
- No significant difference in ischemic stroke incidence was observed between PFO-positive and PFO-negative groups (10.1% vs. 10.3%).
- PFO was not associated with an increased risk of stroke (adjusted hazard ratio: 1.10) or SBI (adjusted odds ratio: 1.15).
Conclusions:
- In this community-based cohort, PFO is not associated with an elevated risk of clinical stroke.
- Subclinical cerebrovascular disease, indicated by SBI, was also not linked to PFO presence.
- These findings suggest PFO may not be a significant independent risk factor for stroke or SBI in the general population.
Objectives:
The purpose of this study was to evaluate the relationship between patent foramen ovale (PFO), ischemic stroke, and subclinical cerebrovascular disease in the general population.
Background:
PFO is found more frequently in stroke patients than in stroke-free controls. However, the PFO-related stroke risk in the general population is not well established, and the relationship between PFO and silent brain infarcts (SBI) is not known.
Methods:
PFO presence was assessed by transthoracic echocardiography with saline contrast injection in 1,100 stroke-free individuals over age 39 of a community-based sample followed for a mean of 11 years. In addition, 360 participants underwent brain magnetic resonance imaging (MRI) for SBI detection. We evaluated the risk of stroke associated with PFO after adjusting for established stroke risk factors and examined the odds of having SBI among those with and without PFO.
Results:
PFO was present in 164 participants (14.9%). Over a mean follow-up of 11.0 ± 4.5 years, 111 ischemic strokes occurred (10.1%), 15 (9.2%) in the PFO+ and 96 (10.3%) in the PFO- groups. The 12.5-year cumulative risk of stroke was 10.1% (standard error: 2.5%) in the PFO+ and 10.4% (standard error: 1.1%) in the PFO- group (p = 0.46). The adjusted hazard ratio for PFO and stroke was 1.10 (95% confidence interval [CI]: 0.64 to 1.91). In the MRI subcohort, PFO was not associated with SBI (adjusted odds ratio: 1.15, 95% CI: 0.50 to 2.62).
Conclusions:
In this community-based cohort, PFO was not associated with an increased risk of clinical stroke or subclinical cerebrovascular disease.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Ischemic Stroke l: Introduction
Cerebral Edema ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

